{"context":{"query":">>mondo>>gwas_study","source_dataset":"mondo","target_dataset":"gwas_study"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0004975,73,MONDO:0004975,44,1]["},"schema":"id|disease_trait|first_author|journal|publication_date","mappings":[{"input":"MONDO:0004975","source":"MONDO:0004975|Alzheimer disease","targets":["GCST000018|Alzheimer's disease (late onset)|Coon KD|J Clin Psychiatry|2007-04-01","GCST000046|Alzheimer's disease (late onset)|Reiman EM|Neuron|2007-06-07","GCST000121|Alzheimer's disease|Webster JA|Neurodegener Dis|2007-11-01","GCST000124|Alzheimer's disease|Li H|Arch Neurol|2007-11-12","GCST000183|Alzheimer's disease|Poduslo SE|Am J Med Genet B Neuropsychiatr Genet|2008-04-30","GCST000237|Alzheimer's disease|Abraham R|BMC Med Genomics|2008-09-29","GCST000255|Alzheimer's disease|Bertram L|Am J Hum Genet|2008-10-29","GCST000310|Alzheimer's disease|Beecham GW|Am J Hum Genet|2009-01-03","GCST000313|Alzheimer's disease|Feulner TM|Mol Psychiatry|2009-01-07","GCST000315|Alzheimer's disease|Carrasquillo MM|Nat Genet|2009-01-11","GCST000479|Alzheimer's disease|Harold D|Nat Genet|2009-09-06","GCST000480|Alzheimer's disease|Lambert JC|Nat Genet|2009-09-06","GCST000484|Alzheimer's disease|Heinzen EL|J Alzheimers Dis|2009-09-11","GCST000614|Brain structure (temporal lobe volume)|Stein JL|Neuroimage|2010-03-01","GCST000676|Alzheimer's disease|Kramer PL|Neurobiol Aging|2010-05-06","GCST000682|Alzheimer's disease|Seshadri S|JAMA|2010-05-12","GCST000808|Alzheimer's disease (late onset)|Naj AC|PLoS Genet|2010-09-23","GCST000864|Alzheimer's disease|Lee JH|Arch Neurol|2010-11-08","GCST000886|Alzheimer's disease|Sherva R|J Alzheimers Dis|2010-11-25","GCST000889|Entorhinal cortical thickness (Alzheimer's disease interaction)|Furney SJ|Mol Psychiatry|2010-11-30","GCST000892|Total ventricular volume (Alzheimer's disease interaction)|Furney SJ|Mol Psychiatry|2010-11-30","GCST000893|Entorhinal cortical volume (Alzheimer's disease interaction)|Furney SJ|Mol Psychiatry|2010-11-30","GCST000895|Whole-brain volume (Alzheimer's disease interaction)|Furney SJ|Mol Psychiatry|2010-11-30","GCST000897|Hippocampal volume (Alzheimer's disease interaction)|Furney SJ|Mol Psychiatry|2010-11-30","GCST000900|Alzheimer's disease biomarkers|Kim S|Neurology|2010-12-01","GCST000980|Alzheimer's disease (late onset)|Wijsman EM|PLoS Genet|2011-02-17","GCST000986|Alzheimer's disease (late onset)|Hu X|PLoS One|2011-02-24","GCST001025|Alzheimer's disease|Hollingworth P|Nat Genet|2011-04-03","GCST001026|Alzheimer's disease (late onset)|Naj AC|Nat Genet|2011-04-03","GCST001087|Alzheimer's disease|Antunez C|Genome Med|2011-05-31","GCST001285|Psychosis and Alzheimer's disease|Hollingworth P|Mol Psychiatry|2011-10-18","GCST001342|Alzheimer's disease|Logue MW|Arch Neurol|2011-12-01","GCST001372|Alzheimer's disease|Meda SA|Neuroimage|2012-01-08","GCST001449|Alzheimer's disease|Lambert JC|Mol Psychiatry|2012-03-20","GCST001529|Alzheimer's disease|Kamboh MI|Transl Psychiatry|2012-05-15","GCST001602|Alzheimer's disease|Gaj P|J Alzheimers Dis|2012-07-11","GCST001658|Alzheimer's disease (late onset)|Cummings AC|Ann Hum Genet|2012-09-01","GCST001743|Alzheimer's disease|Jonsson T|N Engl J Med|2012-11-14","GCST001868|Alzheimer's disease biomarkers|Ramanan VK|Mol Psychiatry|2013-02-19","GCST001915|Alzheimer's disease (cognitive decline)|Sherva R|Alzheimers Dement|2013-03-24","GCST001947|Alzheimer's disease (late onset)|Miyashita A|PLoS One|2013-04-02","GCST001951|Alzheimer's disease biomarkers|Cruchaga C|Neuron|2013-04-04","GCST001963|Alzheimer's disease (late onset)|Reitz C|JAMA|2013-04-10","GCST002161|Alzheimer's disease (neuritic plaque pathology)|Shulman JM|JAMA Neurol|2013-09-01","GCST002245|Alzheimer's disease (late onset)|Lambert JC|Nat Genet|2013-10-27","GCST002422|Alzheimer's disease|Perez-Palma E|PLoS One|2014-04-22","GCST002429|Alzheimer's disease|Nelson PT|Acta Neuropathol|2014-04-27","GCST002462|Alzheimer's disease (SNP x SNP interaction)|Gusareva ES|Neurobiol Aging|2014-05-28","GCST002523|Alzheimer's disease|Jun G|Ann Neurol|2014-07-08","GCST002665|Cerebrospinal fluid levels of Alzheimer's disease-related proteins|Kauwe JS|PLoS Genet|2014-10-23","GCST002775|Alzheimer's disease (survival time)|Wang X|J Alzheimers Dis|2015-02-03","GCST002813|Alzheimer's disease in APOE e4+ carriers|Jun G|Mol Psychiatry|2015-03-17","GCST002814|Alzheimer's disease (APOE e4 interaction)|Jun G|Mol Psychiatry|2015-03-17","GCST002817|Alzheimer's disease in APOE e4- carriers|Jun G|Mol Psychiatry|2015-03-17","GCST002954|Alzheimer's disease (late onset)|Hirano A|Psychiatr Genet|2015-06-05","GCST002983|Alzheimer's disease (late onset)|Tosto G|Ann Clin Transl Neurol|2015-06-18","GCST003423|Alzheimer's disease or small vessel stroke|Traylor M|Ann Neurol|2016-02-23","GCST003452|Posterior cortical atrophy and Alzheimer's disease|Schott JM|Alzheimers Dement|2016-03-15","GCST004246|Alzheimer's disease|Jun GR|Alzheimers Dement|2017-02-06","GCST004247|Alzheimer's disease (APOE e4 interaction)|Jun GR|Alzheimers Dement|2017-02-06","GCST004248|Alzheimer's disease in APOE e4+ carriers|Jun GR|Alzheimers Dement|2017-02-06","GCST004249|Alzheimer's disease in APOE e4- carriers|Jun GR|Alzheimers Dement|2017-02-06","GCST004253|Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)|Lee E|Alzheimers Dement (Amst)|2017-04-23","GCST004880|Alzheimer's disease or type 2 diabetes (pleiotropy)|Wang XF|J Neurol Sci|2017-08-01","GCST005779|Alzheimer's disease|Kulminski AM|Aging (Albany NY)|2018-03-01","GCST005922|Alzheimer's disease or family history of Alzheimer's disease|Marioni RE|Transl Psychiatry|2018-05-18","GCST006121|Alzheimer's disease|Yashin AI|Exp Gerontol|2017-10-26","GCST007303|Alzheimer's disease or cardiovascular risk factors (pleiotropy)|Broce IJ|Acta Neuropathol|2018-11-09","GCST007318|Alzheimer's disease with visuospatial domain impairment|Mukherjee S|Mol Psychiatry|2018-12-04","GCST007319|Alzheimer's disease (late onset)|Jansen IE|Nat Genet|2019-01-07","GCST007320|Alzheimer's disease or family history of Alzheimer's disease|Jansen IE|Nat Genet|2019-01-07","GCST007330|Alzheimer's disease with memory domain impairment|Mukherjee S|Mol Psychiatry|2018-12-04","GCST007331|Alzheimer's disease|Mukherjee S|Mol Psychiatry|2018-12-04","GCST007332|Alzheimer's disease with multiple cognitive domain impairments|Mukherjee S|Mol Psychiatry|2018-12-04","GCST007333|Alzheimer's disease with no specific cognitive domain impairment|Mukherjee S|Mol Psychiatry|2018-12-04","GCST007334|Alzheimer's disease with language domain impairment|Mukherjee S|Mol Psychiatry|2018-12-04","GCST007600|Alzheimer's disease|Nazarian A|Alzheimers Res Ther|2019-01-12","GCST007825|Alzheimer's disease or fasting glucose levels (pleiotropy)|Zhu Z|Hum Genet|2019-02-25","GCST007826|Alzheimer's disease or fasting insulin levels (pleiotropy)|Zhu Z|Hum Genet|2019-02-25","GCST007827|Alzheimer's disease or HDL levels (pleiotropy)|Zhu Z|Hum Genet|2019-02-25","GCST008056|Alzheimer's disease (SNP x SNP interaction)|Gusareva ES|Neurobiol Aging|2018-08-09","GCST008437|Alzheimer's disease in hypertension-negative individuals|Nazarian A|Geroscience|2019-05-05","GCST008438|Alzheimer's disease in hypertension|Nazarian A|Geroscience|2019-05-05","GCST009019|Alzheimer's disease|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009020|Alzheimer's disease|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009021|Alzheimer's disease|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009022|Alzheimer’s disease (clinical subgroup AD+)|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009023|Alzheimer’s disease (clinical subgroup AD++)|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009024|Alzheimer’s disease (clinical subgroup AD+++)|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009025|Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+)|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009026|Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)|Moreno-Grau S|Alzheimers Dement|2019-08-13","GCST009496|Alzheimer's disease (onset between ages 58 and 79)|Lo MT|Neurobiol Aging|2019-03-12","GCST009497|Alzheimer's disease (onset at age over 80)|Lo MT|Neurobiol Aging|2019-03-12","GCST010764|Alzheimer's disease (time to event)|Bi W|Am J Hum Genet|2020-06-23","GCST011070|Alzheimer's disease in depression|Steffens DC|Int Psychogeriatr|2020-07-09","GCST011300|Alzheimer's disease or posttraumatic stress syndrome (pleiotropy)|Lutz MW|Alzheimers Dement|2020-06-26","GCST011696|Alzheimer's disease|Kunkle BW|JAMA Neurol|2020-10-19","GCST012182|Alzheimer's disease|de Rojas I|Nat Commun|2021-06-07","GCST012214|Alzheimer's disease|Shigemizu D|Transl Psychiatry|2021-03-03","GCST012215|Alzheimer's disease|Shigemizu D|Transl Psychiatry|2021-03-03"]}]}